Discuss Epitalon (Epithalon) on glp1chat
Join the forum to discuss research with other members.
At a glance
In laboratory studies, Epitalon has been linked to changes in telomerase activity, a process related to the protective ends of chromosomes. Researchers also study its effects on cell aging and daily biological rhythms. Those cell changes are not a measure of lifespan.
Telomeres are protective caps at the ends of chromosomes, and telomerase is one enzyme involved in maintaining them. Some laboratory experiments report changes in this pathway after Epitalon exposure. Researchers also examine daily rhythm and cell-stress signals. A shift in a cell marker is a starting point for research, not proof that the peptide slows aging or extends a human life.
Potential benefits & side effects
Interpret each outcome in the context of the study population, formulation and evidence type. Research findings do not establish a personal treatment outcome.
Potential benefits & research findings
Cellular and animal endpoints form part of the source discussion. Evidence involving other pineal preparations must be distinguished from evidence for this exact peptide.[2][9][3]
Read the original publications to see the measured endpoints, comparator, duration and uncertainty. Mechanistic plausibility and a favorable experimental result are different from demonstrated clinical benefit.
Side effects & evidence limitations
Interpret the reported adverse effects together with the study population, route and observation period. Small or short studies can miss uncommon and delayed harms. Evidence from a related compound does not establish the safety of Epitalon (Epithalon).
Source-reported adverse effects and cautions
Sources are available for independent reading. Individual claims and research schedules have not yet undergone an independent clinical review by Pep Science.
- Editorial responsibility
- Pep Science editorial desk
- Last independent review
- Not yet recorded
SPECIFICATIONS & SOURCE SCHEDULES
Explore a vial size
Select the exact formulation. Vial content, target dose and prepared concentration are different measurements.
Showing 10 mg · 1 source tables
Standard Protocol (2 mL = 5 mg/mL)
| Phase | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Days 1–20 (Cycle On) | 5,000 mcg (5 mg) | 100 units (1.00 mL) |
| Weeks 4–26 (Cycle Off) | 0 mcg | — |
Frequency: Inject once daily subcutaneously, preferably in the evening or at bedtime to synergize with natural melatonin rhythms[3]. Complete 20 consecutive days, then observe a 4–6 month off-cycle before repeating (typically 2 cycles per year)[5].
Additional schedule context & duration
Concise summary of the once-daily regimen.
- Goal: Support telomere maintenance, melatonin regulation, and geroprotective effects over time[2].
- Schedule: Daily subcutaneous injections for 20 consecutive days, followed by 4–6 months off-cycle.
- Dose: 5,000 mcg (5 mg) daily.
- Reconstitution: 2.0 mL per 10 mg vial (5 mg/mL) for accurate unit measurements.
- Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
Suggested daily approach based on published research protocols.
- Standard Dose: 5,000 mcg (5 mg) once daily subcutaneously[5].
- Alternative: 10 mg/day for 10 days (same total cycle dose of 100 mg).
- Frequency: Once per day (subcutaneous), preferably at bedtime.
- Cycle Length: 20 consecutive days on, then 4–6 months off.
- Timing: Evening administration recommended; rotate injection sites daily.
Read this protocol on Pep Science → · View cited documents ↓
Preparation
Reconstitution Steps
- Draw 2.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Storage Instructions
Proper storage preserves peptide quality.
- Lyophilized: Store at −20 °C (−4 °F) for long-term; refrigerate at 2–8 °C (35.6–46.4 °F) for routine storage; minimize moisture exposure[6].
- Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 2–4 weeks and avoid freeze–thaw[7].
- Allow vials to reach room temperature before opening to reduce condensation uptake.
Injection Technique
General subcutaneous guidance from clinical best-practice resources[8].
- Clean the vial stopper and skin with alcohol; allow to dry.
- Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[10][11].
- Do not aspirate for subcutaneous injections; inject slowly and steadily[10].
- Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[8].
Materials & quantity planning
Source materials checklist · 10 mg
Plan based on a 20-day daily protocol at 5 mg/day.
-
Peptide Vials (Epitalon, 10 mg each):
- 20-day cycle (5 mg/day): 10 vials (each vial yields 2 doses)
-
Insulin Syringes (U-100):
- Per cycle: 20 syringes (1/day)
-
Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution.
- 20-day cycle (10 vials): 20 mL → 2 × 10 mL bottles
-
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per cycle: 40 swabs (2/day) → recommend 1 × 100-count box
Calculate a phased quantity
Enter each finite phase from the schedule you are studying. Open-ended phases need an explicit duration. Calculation uses 10 mg per vial and 2 mL per vial.
Complete each phase to calculate totals.
Quantity estimates exclude preparation losses and expiry. Follow the formulation’s handling and disposal requirements.
FOLLOW THE EVIDENCE
References & further reading
Original publications and source documents cited across this product’s variants. A listed source is not an independent endorsement of a dosing schedule.
- 02
Research publication
PMC/Biogerontology — Epitalon increases telomere length in human cell lines through telomerase upregulation (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑ - 03
Research publication
Neuroendocrinology Letters (PubMed) — Synthetic tetrapeptide Epitalon restores neuroendocrine regulation in senescent monkeys (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 04
Research publication
Bull Exp Biol Med (PubMed) — Geroprotective effect of epithalamine in elderly with accelerated aging (12-year RCT) (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 08
Source document
Johns Hopkins Arthritis Center — How to Give a Subcutaneous Injection (patient education guide) (opens in a new tab)www.hopkinsarthritis.org
Back to overview ↑ - 09
Source document
Wikipedia — Epitalon (overview of Hayflick limit studies and telomerase activation) (opens in a new tab)en.wikipedia.org
Back to overview ↑ - 10
Public health resource
CDC — Vaccine administration: subcutaneous route (angle/site; no aspiration) (opens in a new tab)www.cdc.gov
Back to overview ↑ - 11
- 12
Public health resource
NCBI Bookshelf — Best practices for injection (asepsis, preparation, and administration) (opens in a new tab)www.ncbi.nlm.nih.gov
Back to overview ↑ - 13
Research publication
Subcutaneous Drug Injection Review (PMC) — Pharmacologic considerations of the subcutaneous route (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑
Continue exploring
Related topics are not interchangeable compounds or formulations.